PharmaCyte Biotech Inc (PMCB)
2.10
+0.01
(+0.48%)
USD |
NASDAQ |
May 17, 16:00
2.12
+0.02
(+0.95%)
After-Hours: 20:00
PharmaCyte Biotech 1 Year Total Returns (Daily): -32.04% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -32.04% |
May 16, 2024 | -32.58% |
May 15, 2024 | -32.36% |
May 14, 2024 | -30.87% |
May 13, 2024 | -31.70% |
May 10, 2024 | -21.35% |
May 09, 2024 | -21.70% |
May 08, 2024 | -22.86% |
May 07, 2024 | -24.64% |
May 06, 2024 | -23.21% |
May 03, 2024 | -25.96% |
May 02, 2024 | -25.77% |
May 01, 2024 | -27.05% |
April 30, 2024 | -27.40% |
April 29, 2024 | -27.40% |
April 26, 2024 | -29.19% |
April 25, 2024 | -29.10% |
April 24, 2024 | -26.17% |
April 23, 2024 | -28.52% |
April 22, 2024 | -25.50% |
April 19, 2024 | -28.38% |
April 18, 2024 | -26.17% |
April 17, 2024 | -28.62% |
April 16, 2024 | -27.12% |
April 15, 2024 | -28.47% |
Date | Value |
---|---|
April 12, 2024 | -24.92% |
April 11, 2024 | -22.30% |
April 10, 2024 | -23.65% |
April 09, 2024 | -21.50% |
April 08, 2024 | -18.43% |
April 05, 2024 | -16.55% |
April 04, 2024 | -13.10% |
April 03, 2024 | -15.49% |
April 02, 2024 | -14.78% |
April 01, 2024 | -15.98% |
March 28, 2024 | -16.55% |
March 27, 2024 | -13.78% |
March 26, 2024 | -15.57% |
March 25, 2024 | -14.19% |
March 22, 2024 | -15.28% |
March 21, 2024 | -16.03% |
March 20, 2024 | -17.65% |
March 19, 2024 | -26.21% |
March 18, 2024 | -30.69% |
March 15, 2024 | -31.58% |
March 14, 2024 | -29.17% |
March 13, 2024 | -31.49% |
March 12, 2024 | -32.53% |
March 11, 2024 | -31.16% |
March 08, 2024 | -30.64% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.11%
Minimum
Feb 22 2022
56.54%
Maximum
Feb 24 2023
-36.04%
Average
-35.35%
Median
Apr 20 2020
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -52.96% |
AIM ImmunoTech Inc | -19.40% |
IGC Pharma Inc | 69.70% |
NovaBay Pharmaceuticals Inc | -83.53% |
Protalix BioTherapeutics Inc | -51.69% |